This inventor holds 3 USPTO granted patents and 1 published patent application and 3 EPO patents. Top assignees: Samsung Fine Chemicals Co., Ltd., Lotte Fine Chemical Co., Ltd.. Active years: 2014-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2014-2017
Title: Min Gyu Song: Innovator in Enteric Hard Capsule Technology
Introduction
Min Gyu Song is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of enteric hard capsules. With a total of 3 patents to his name, his work focuses on improving the formulation and preparation methods of these capsules.
Latest Patents
Min Gyu Song's latest patents include innovative compositions for enteric hard capsules. One of his notable inventions is a composition that includes polyol with at least three hydroxyl groups. This composition is designed to delay the separation of salt from the capsule during storage. Another patent details an aqueous composition for enteric hard capsules, which consists of an enteric base material, a capsule forming aid, and a neutralizing agent. The method of preparing these capsules involves several steps, including preheating the aqueous composition and forming a film on a mold pin.
Career Highlights
Throughout his career, Min Gyu Song has worked with reputable companies such as Samsung Fine Chemicals Co., Ltd. and Lotte Fine Chemical Co., Ltd. His experience in these organizations has contributed to his expertise in the field of chemical engineering and pharmaceutical formulations.
Collaborations
Min Gyu Song has collaborated with notable colleagues, including Jin Ryul Son and Hyon Ho Baek. These partnerships have likely enhanced his research and development efforts in the area of enteric hard capsules.
Conclusion
Min Gyu Song is a distinguished inventor whose work in enteric hard capsule technology has the potential to impact the pharmaceutical industry significantly. His innovative approaches and collaborations reflect his commitment to advancing this field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile